The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-04 · 1880 (2) · 189273
DOI: 10.1016/j.bbcan.2025.189273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-04. Verfasst von Jiayi Lyu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Zhongshan School of …. Hauptthemen laut MEDLINE: Serpins, Nerve Growth Factors, Eye Proteins, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Tumors are diseases caused by abnormal cell division and growth, which can be life-threatening if not treated properly. Serpin inhibitors play a crucial role in regulating pathophysiological process and are promising drug targets. Kallistatin (SERPINA4) and Pigment Epithelium-Derived Factor (PEDF, SERPINF1) are two serpins that lack protease inhibitory activity but are abundant in blood. They exhibit anti-angiogenic effects and are involved in tumorigenesis. The pathogenic role and mechanism of Kallistatin and pigment epithelium-derived factor (PEDF) have been extensively studied for their potential use in cancer therapy. Kallistatin and PEDF play significant roles in controlling tumor growth and progression. While they share some common mechanisms of action, such as promoting apoptosis and inhibiting angiogenesis, they also have distinct differences in effectiveness and range of anti-tumor activities. This review compares and contrasts the expression patterns, structural features, expression regulation, disease roles, signaling pathways, and potential clinical value of Kallistatin and PEDF, aiming to provide a comprehensive understanding of their biomedical and clinical potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China.
- Department of Biochemistry and Molecular Biology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Guangdong Province Key Laboratory of Brain Function and Disease, Zhongshan School of Medic…
- Department of Biochemistry and Molecular Biology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; Guangdong Engineering & Technology Research Center for Gene Manipulation and Biomacromolec…
- Department of Biochemistry and Molecular Biology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China; China Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Edu…
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Natural Science Foundation
Zitieren
APA
Lyu, J., Wang, S., Chen, J., Yang, X., Gao, G., & Zhou, T. (2025). The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(2), 189273. https://doi.org/10.1016/j.bbcan.2025.189273
Vancouver
Lyu J, Wang S, Chen J, Yang X, Gao G, Zhou T. The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(2):189273. doi:10.1016/j.bbcan.2025.189273
BibTeX
@article{Lyu2025,
author = {Lyu, Jiayi and Wang, Simin and Chen, Jingnan and Yang, Xia and Gao, Guoquan and Zhou, Ti},
title = {The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {2},
pages = {189273},
doi = {10.1016/j.bbcan.2025.189273}
}
EUVIMED